Clinical Trial Update: Phase ⅡStudy of Pinocembrin Injection to Treat Ischemic Stroke [Phase 2]

View source ↗

Summary

Phase II trial of Pinocembrin Injection for ischemic stroke has been suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• Pinocembrin Injection (pinocembrin)

Snippet

Sponsor: CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | Conditions: Ischemic Stroke | Phase 2 | Status: SUSPENDED